Results 11 to 20 of about 20,336 (222)

Research Models for Studying Vascular Calcification [PDF]

open access: yes, 2020
Calcification of the vessel wall contributes to high cardiovascular morbidity and mortality. Vascular calcification (VC) is a systemic disease with multifaceted contributing and inhibiting factors in an actively regulated process.
Babic, Milen   +4 more
core   +1 more source

Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study

open access: yesFrontiers in Medicine, 2023
BackgroundHyperphosphatemia remains a major complication in patients with Continuous ambulatory peritoneal dialysis (CAPD) leading to increased morbidity and mortality. However, phosphorus management still has many challenges.ObjectiveThis study aimed to
Xiaojing Yin   +3 more
doaj   +1 more source

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease

open access: yesJournal of Veterinary Internal Medicine, 2021
Background Fibroblast growth factor (FGF)‐23 is increased first in the sequence of changes associated with chronic kidney disease (CKD)‐mineral and bone disorder.
Hirosumi Miyakawa   +5 more
doaj   +1 more source

EOS789, pan‐phosphate transporter inhibitor, ameliorates the progression of kidney injury in anti‐GBM‐induced glomerulonephritis rats

open access: yesPharmacology Research & Perspectives, 2022
Hyperphosphatemia associated with chronic kidney disease (CKD) not only dysregulates mineral metabolism and bone diseases, but also strongly contributes to the progression of kidney disease itself.
Yoshinori Tsuboi   +7 more
doaj   +1 more source

Psödohipoparatiroidi Tip 2: Olgu Sunumu

open access: yesGenel Tıp Dergisi, 2021
Psödohipoparatiroidi, parathormona karşı hedef organ düzeyinde cevapsızlık nedeniyle hipokalsemi ve hiperfosfatemi gelişmesiyle karakterize bir bozukluktur.
Özlem Güleç Şen   +2 more
doaj   +1 more source

Hyperphosphatemia is a complication of reduced kidney functions and limit for renoprotection

open access: yesPočki, 2020
Hyperphosphatemia in patients with chronic kidney disease (CKD) is an important complication of impaired renal function and is associated with negative clinical consequences such as cardiovascular calcification, bone disease and secondary ...
S.V. Kushnirenko
doaj   +1 more source

Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies [PDF]

open access: yes, 2018
Hyperphosphatemic familial tumoral calcinosis (HFTC)/hyperostosis-hyperphosphatemia syndrome (HHS) is an autosomal recessive disorder of ectopic calcification due to deficiency of or resistance to intact fibroblast growth factor 23 (iFGF23). Inactivating
Burbelo   +14 more
core   +1 more source

Hyperphosphatemia is associated with high mortality in severe burns. [PDF]

open access: yesPLoS ONE, 2018
Phosphate level is often deranged during acute illness, regardless of the presence of kidney injury or not. A few studies described that hypophosphatemia may associated with outcome in patients admitted to the burn unit, but the literatures for ...
George Kuo   +10 more
doaj   +1 more source

Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review

open access: yesKidney Medicine, 2021
Phosphate absorption occurs in the gastrointestinal tract through paracellular absorption and transcellular transport. The paracellular pathway does not saturate and has a significantly higher absorption capacity than does the transcellular pathway ...
Steven N. Fishbane, Sagar Nigwekar
doaj   +1 more source

An Unusual Combination of Neurological Manifestations and Sudden Vision Loss in a Child with Familial Hyperphosphatemic Tumoral Calcinosis [PDF]

open access: yes, 2019
Hyperphosphatemia in the absence of renal failure is an unusual occurrence, particularly in children, but is a common primary feature of familial hyperphosphatemic tumor calcinosis.
Acton, Dena   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy